Data from the study was presented at 11th Annual American Association for Cancer Research International Conference on Frontiers in Cancer Prevention Research in Anaheim, Calif.
Researchers found that people with both allergies experienced an approximately 17 percent lower risk for dying from colorectal cancer. People with only one of the conditions had little reduction in risk.
“Having both of these conditions could indicate that you are more likely to develop allergy-related immune responses that lower your risk for developing fatal colorectal cancer,” said Eric Jacobs, PhD, strategic director of pharmacoepidemiology at the American Cancer Society, in the release. “If allergy-related immune responses are lowering colorectal cancer mortality in some individuals, that would imply that a similar kind of response might be inducible by a vaccine.”
Related Articles on Colorectal Cancer:
GIQuIC Registry Surpasses 100,000 Colonoscopy Cases
Study: Rate of Colorectal Cancer Death Higher for Poor People
University of Michigan Health System Opens New Colorectal Cancer Clinic
